Nordea Investment Management AB lifted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 157,457 shares of the medical instruments supplier’s stock after purchasing an additional 16,777 shares during the quarter. Nordea Investment Management AB’s holdings in Mettler-Toledo International were worth $220,718,000 at the end of the most recent quarter.
Several other hedge funds have also recently modified their holdings of the stock. Versant Capital Management Inc grew its position in Mettler-Toledo International by 42.1% in the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares during the last quarter. SJS Investment Consulting Inc. increased its stake in Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares during the period. Root Financial Partners LLC purchased a new position in Mettler-Toledo International during the 3rd quarter worth $42,000. Salomon & Ludwin LLC acquired a new stake in shares of Mettler-Toledo International in the 3rd quarter worth $43,000. Finally, Quantbot Technologies LP acquired a new stake in shares of Mettler-Toledo International in the 3rd quarter worth $49,000. 95.07% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
MTD has been the topic of a number of recent analyst reports. Wells Fargo & Company boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Morgan Stanley reduced their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 10th. Barclays lowered their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a report on Monday, December 15th. The Goldman Sachs Group assumed coverage on Mettler-Toledo International in a research report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 target price on the stock. Finally, Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a report on Monday, December 15th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $1,463.75.
Insider Activity
In other news, CFO Shawn Vadala sold 800 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,456,714.56. The trade was a 13.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.77% of the company’s stock.
Mettler-Toledo International Stock Up 1.3%
Shares of MTD opened at $1,205.77 on Monday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17. The company has a 50-day simple moving average of $1,351.42 and a 200-day simple moving average of $1,366.03. The company has a market capitalization of $24.42 billion, a PE ratio of 28.63, a P/E/G ratio of 2.53 and a beta of 1.43.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the previous year, the firm earned $12.41 earnings per share. The firm’s revenue was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.
Mettler-Toledo International Profile
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
